Skip to content
healthcare.dev

Cisatracurium Besylate

NDC 70069-141, Cisatracurium Besylate, injection, from Somerset Therapeutics, LLC.

Product NDC
70069-141
Status
Listed
Labeler
Somerset Therapeutics, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206791
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70069-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
70069-141-01700690141011 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL
70069-141-107006901411010 VIAL in 1 CARTON (70069-141-10) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ed91f65b-e002-43bd-bfa0-5ce8b89119e6

Use it

Look up 70069-141 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70069-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70069-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.